BioSyntech Retains RCG Capital Markets Group, Inc. to Execute National Financial Relations Program in the US.

Business Editors

LAVAL, Quebec--(BUSINESS WIRE)--Jan. 14, 2002

BioSyntech, Inc. (OTCBB:BSYI), a leading developer of advanced biomaterials specializing in tissue repair and therapeutic delivery products, today announced the retention of RCG Capital Markets Group, Inc. to implement and maintain a proactive national investor relations program in the United States.

RCG will be actively engaged in increasing the awareness within the professional investment community for BioSyntech and conveying the investment potential of the Company. In conjunction with the Company's management team, RCG will actively participate in developing the Company's perception and positioning activities, arrange and coordinate presentations and serve as the primary information resource on behalf of the Company to all levels of the professional investment community throughout the United States. Additionally, RCG will provide media relations activities and comprehensive information fulfillment services for all inquiries.

Dr. Amine Selmani, chief executive officer of BioSyntech, commented, "BioSyntech has made significant strides in its evolution as a Company, and we believe RCG will be instrumental in communicating our progress to the professional investment community and assisting BioSyntech in recognizing appropriate shareholder value. RCG's experience, particularly within the biotechnology sector, provides us with confidence that they can meet our expectations, and we are certain the firm's expertise will prove invaluable going forward."

A. Max Ramras, president and chief executive officer of RCG Capital Markets Group, said, "We are extremely pleased to be working with BioSyntech. The Company has an aggressive marketing strategy in place and RCG believes BioSyntech is strategically positioned to rapidly capture market share in many areas of the biomedical, pharmaceutical and biotechnology industries. The Company is aggressively progressing towards pursuing U.S., Canadian and European regulatory approvals for their technology, and RCG will work to leverage those milestone events within the professional investment community."

Based in Phoenix, Arizona, RCG Capital Markets Group, Inc. provides financial relations consulting services to leading-edge emerging-growth small- and mid-cap companies trading on all major exchanges. The firm's mission is to create "efficient markets" by securing meaningful and continuous national investment community sponsorship for its client companies.

This press release contains certain "forward looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in the company's filings with the regulatory authorities having jurisdiction.

No regulatory authority has approved or disapproved the content of this release.